| Name | Title | Contact Details |
|---|---|---|
Rocky Rankin |
Vice President of Technology | Profile |
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Cox2M is a new Internet of Things (IoT) business line within Cox Communications that provides complete asset tracking and monitoring solutions.
ReputationImpression is a San Diego, CA-based company in the Software and Internet sector.
Applied Intuition offers software for the simulation, development, and validation of self-driving cars such as advanced driver assistance systems (ADAS), autonomous vehicles (AVs), automated driving systems (ADS), and other types of autonomous systems.
Tines is a no-code automation platform designed to allow security and operations teams to connect their technology stack and automate any repetitive manual task, regardless of complexity.